The neoBLUE blanket LED Phototherapy System consists of a light box, fiberoptic blanket with cable, blanket mattress, disposable mattress covers, and
power supply. The neoBLUE blanket device is a portable phototherapy light that delivers a narrow band of high-intensity blue light via a single blue light
emitting diode (LED) to provide treatment for neonatal hyperbilirubinemia. The neoBLUE blanket device provides phototherapy underneath the infant and
can be used within existing patient enclosures or while holding the infant.
Position fiberoptic blanket with mattress in a bassinet, open bed, radiant warmer, or incubator.
Position light box and insert fiberoptic cable into fiberoptic coupling.
Connect power supply to suitable wall outlet and to light box. Power supply cords should be safely routed.
Apply disposable cover to blanket mattress.
Switch on power.
Check intensity of the light using a radiometer per your institution’s procedures (see “Measuring Intensity”).
Shield infant’s eyes with protective eye shields designed for use during phototherapy.
Place infant on top of neoBLUE blanket covered mattress.
Monitor patient during treatment.
Biliband® Eye Protectors
Micro (PN 900644)
Premature (PN 900643)
Regular (PN 900642)
10. When finished, switch power to stand-by and remove light from therapy area.
Over-Temperature Indicator Light
Vent (both sides)
(w/mattress & disposable cover)
Disposable Mattress Cover
Note: The neoBLUE blanket device comes with a large or small size blanket.
The infant may be swaddled or covered with a blanket for warmth during phototherapy. During periods when the infant is being held
and positioned so that their eyes cannot be exposed to the light, protective eye shields can be removed.
If using an incubator, position fiberoptic cable through one of the incubator
ports then insert into light box located outside the incubator. The light box may
be placed on a flat surface or mounted to a pole using optional hardware. If
additional surface area coverage is required, neoBLUE overhead lights may be
used in conjunction with the neoBLUE blanket device.
It is recommended
that the intensity of
the light be checked
before each use, or at
least every six months.
is taken near the
center of the effective
treatment area on top
of the mattress and
disposable cover. The
light intensity output
of the neoBLUE blanket system was factory set to
30-35 µW/cm²/nm using a neoBLUE Radiometer.
The light output can be adjusted by a biomedical
engineer. Please refer to the Service Manual for
WARNING! Select only infants for whom phototherapy has been prescribed
WARNING! The intensity level and duration of treatment should be prescribed by the physician for each patient.
WARNING! Intensive phototherapy (>30 µW/cm²/nm) may not be appropriate for all infants (i.e. preterm infants ≤1000g).¹
WARNING! Eye Protection: Do not look directly into the emitted light. During treatment, protect the baby’s eyes with eye patches or equivalent,
when eyes can be exposed to the phototherapy light. Patients adjacent to the light may also need to be protected with eye patches or equivalent.
WARNING! Do Not Use without blanket mattress and disposable blanket cover: The device must be used with the supplied Natus mattress and
cover in place to ensure proper treatment uniformity.
WARNING! To avoid overheating the light box, check that the air vents are not covered with blankets or clothing or positioned against
WARNING! To avoid any entanglement, always place the infant on the mattress with their head opposite the end
where the fiberoptic cable is attached.
WARNING! Monitor infants regularly during treatment per your institution’s procedures.
WARNING! Some individuals are sensitive to blue light. You may need to turn off the neoBLUE blanket LED Phototherapy System
while attending to the infant.
For a complete list of warnings/cautions and additional information, please refer to the neoBLUE blanket user manual. For service information,
please refer to your service manual or contact Natus Medical Technical Service, or your authorized service representative.
¹ Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation.
Journal of Perinatology (2012) 32, 660-664.
Natus…Where Babies Come First.®
Natus Medical Incorporated
5900 First Avenue South
Seattle, WA 98108 USA
Natus Europe GmbH
Visit our NERVE Center® education portal at nervecenter.natus.com
Register for the Neonatal Care Academy at www.neonatalcareacademy.com
for expanded educational courses & more
© 2016 Natus Medical Incorporated. All Rights Reserved. All product names appearing on this document are trademarks
or registered trademarks owned, licensed to, promoted or distributed by Natus Medical Incorporated,
its subsidiaries or affiliates.